Company news

WuXi XDC Cayman, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026

October 6, 2026

WuXi XDC Celebrates GMP Release of Singapore Site, Ushering in a New Era of Global Expansion

September 21, 2026

Interim Report 2026

September 18, 2026

WuXi XDC Out-Licenses WuXiTecan-2 Payload-Linker Technology Platform to Ona Therapeutics to Advance Novel ADC Research and Development

September 17, 2026

WuXi XDC Delivers Strong First Half 2026 Performance, with Improving Margins and Profitability Further Strengthening Global ADC/XDC CRDMO Leadership

August 24, 2026

WuXi XDC Achieves GMP Release of BCM3 Facility at Singapore Site, Enabling Global Clients with Professional Excellence

August 18, 2026

WuXi XDC Delivers Exceptional Performance in 2025, Reinforcing Global Leadership in Bioconjugate CRDMO

March 23, 2026

WuXi XDC Enters Strategic Collaboration with Earendil Labs on WuXiTecan-2 Payload-Linker Technology Platform

February 27, 2026

Earendil Labs Enters Strategic Collaboration with WuXi XDC on WuXiTecan-2 Payload-Linker Technology Platform

February 27, 2026

WuXi XDC Named the Winner of "Best CDMO" and "Best CRO" at 2025 World ADC Awards

November 6, 2025

The 2025 BPD Singapore Conference Has Concluded Successfully! Jointly Embarking on a New Journey for Global Development

September 26, 2025

WuXi XDC Continues to Deliver Robust Business Growth and Financial Results in 1H 2025, Strengthening Global CRDMO Leadership Position in Bioconjugates Industry

August 18, 2025

WuXi XDC Included in MSCI China All Share Index

August 8, 2025

WuXi XDC Achieves GMP Release of Newly Launched DP3 Facility at Wuxi Site, Scaling Further Drug Product Manufacturing Capacity

August 4, 2025

WuXi XDC Announces the Mechanical Completion of its Singapore Site, Accelerating the Global Expansion of Bioconjugates Manufacturing

July 1, 2025

WuXi XDC Received Multiple Awards from 2025 Extel (previously "Institutional Investor") Ranking in Diverse Categories

May 19, 2025

WuXi XDC Achieved Another Remarkable Year with Extraordinary Business Performance and Financial Results for 2024

March 24, 2025

WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025

March 13, 2025

WuXi XDC and AbTis Announce Strategic Partnership to Advance Next-Generation ADCs

March 11, 2025

WuXi XDC and LigaChem Biosciences Strengthen Partnership with Expanded MOU to Accelerate ADC Development

February 25, 2025

WuXi XDC Reports Strong Business Updates with Superior Financial Results in 1H 2024: Poised for Future Growth

August 20, 2024

WuXi XDC Delivers Outstanding Performance in 2023 with over 110% Year-On-Year Growth for Both Revenue and Adjusted Net Profit and Achieves Significant Corporate Milestones

March 26, 2024

Decks

The 5 newest of 12 decks. Every deck is listed under its year.